Teprenone
Top View
- Proton Pump Inhibitor Alone Vs Proton Pump Inhibitor Plus Mucosal Protective Agents for Endoscopic Submucosal Dissection Induced
- Rebamipide, a Cytoprotective Drug, Increases Gastric Mucus Secretion in Human: Evaluations with Endoscopic Gastrin Test
- Nasally Administrable Compositions Containing Physiologically Active Peptides
- Customs Tariff - Schedule Xxi - 1
- Gut Microbiota in NSAID Enteropathy: New Insights from Inside
- The Effect of Lactobacillus Reuteri Supplementation in Helicobacter Pylori Infection: a Placebo-Controlled, Single-Blind Study
- (12) Patent Application Publication (10) Pub. No.: US 2005/0089577 A1 Yokoyama Et Al
- United States Patent (19) 11) Patent Number: 5,620,964 Roth Et Al
- Evidence-Based Clinical Practice Guidelines for Peptic Ulcer Disease 2020
- Managing Proton Pump Inhibitor Use in Older Adults Tool
- Lopresti, Michael1 1Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan
- (2) Patent Application Publication (10) Pub. No.: US 2016/0354315 A1 Li (43) Pub
- Healing-Promoting Action of Teprenone, a New Antiulcer Agent on Acetic Acid Ulcer in Rats
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
- (12) United States Patent (10) Patent No.: US 8,673,360 B2 Nagata Et Al
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Summary of APSMI Country Report 2019